Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Goldman Sachs Takes Control Of Synthon
Current Owners BC Partners Sell Majority Share But Retain ‘Significant Stake’
Dec 16 2024
•
By
Dave Wallace
Goldman Sachs has laid out its rationale for the Synthon deal
(Shutterstock)
More from Deals
More from Strategy